Literature DB >> 27525710

Postoperative Complications and Readmission Rates Following Surgery for Cerebellopontine Angle Schwannomas.

Hossein Mahboubi1, Yarah M Haidar, Omid Moshtaghi, Kasra Ziai, Yaser Ghavami, Marlon Maducdoc, Harrison W Lin, Hamid R Djalilian.   

Abstract

OBJECTIVE: To investigate the 30-day postoperative complication, readmission, and reoperation rates following surgery for cerebellopontine angle (CPA) schwannomas. STUDY
DESIGN: Cross-sectional analysis.
SETTING: National surgical quality improvement program dataset (NSQIP) 2009 through 2013. PATIENTS: All surgical cases with an International Classification of Diseases, 9th edition, Clinical Modification (ICD-9-CM) diagnosis code of 225.1, benign neoplasms of cranial nerves, and one of the following current procedural terminology (CPT) codes, were included: 61616, 61526, 61530, and 61520. INTERVENTION(S): Surgical resection as indicated by the CPT codes above. MAIN OUTCOME MEASURE(S): Demographics, comorbidities, 30-day postoperative complications, readmission rate, and reoperation rate.
RESULTS: Overall, 404 cases were identified, of which 42.6% were men. The average age was 51 years. Comorbidities were present in 45.3%. NSQIP-tracked complications occurred in 9.7% of patients. Most common complications were wound infections including surgical-site infection and wound dehiscence (11 patients, 2.7%), sepsis (10 patients, 2.5%), blood loss (nine patients, 2.2%), and deep vein thrombosis (DVT; seven patients, 1.7%). Mortality occurred in four patients (1.0%). The complication rate was statistically higher in patients with comorbidities versus those without (10.2% versus 4.1%, p = 0.04). Patients with complications were more likely to undergo reoperation (2.5% with versus 4.1% without, p = 0.001). Unplanned readmissions occurred in 41 cases (10.1%) and reoperations occurred in 23 patients (5.7%).
CONCLUSIONS: Most common NSQIP-tracked complications in excision of CPA neoplasms are infections, sepsis, blood loss, and deep vein thrombosis (DVT). Further, investigation of patients with unplanned readmission and reoperation are warranted. Neurotologists need to take an active role in the data to be gathered in the NSQIP database as it relates to vestibular schwannomas.

Entities:  

Mesh:

Year:  2016        PMID: 27525710      PMCID: PMC5929100          DOI: 10.1097/MAO.0000000000001178

Source DB:  PubMed          Journal:  Otol Neurotol        ISSN: 1531-7129            Impact factor:   2.311


  21 in total

1.  Vestibular schwannomas in the modern era: epidemiology, treatment trends, and disparities in management.

Authors:  Ranjith Babu; Richa Sharma; Jacob H Bagley; Jeffrey Hatef; Allan H Friedman; Cory Adamson
Journal:  J Neurosurg       Date:  2013-02-22       Impact factor: 5.115

Review 2.  Nonschwannoma tumors of the cerebellopontine angle.

Authors:  David R Friedmann; Bartosz Grobelny; John G Golfinos; J Thomas Roland
Journal:  Otolaryngol Clin North Am       Date:  2015-06       Impact factor: 3.346

3.  Complications and mortality following surgery for oral cavity cancer: analysis of 408 cases.

Authors:  Zachary G Schwam; Julie A Sosa; Sanziana Roman; Benjamin L Judson
Journal:  Laryngoscope       Date:  2015-06-09       Impact factor: 3.325

4.  Audiologic evaluation of vestibular schwannoma and other cerebellopontine angle tumors.

Authors:  Sang Hoon Kim; Sung Ho Lee; Seok Keun Choi; Young Jin Lim; Se Young Na; Seung Geun Yeo
Journal:  Acta Otolaryngol       Date:  2015-10-19       Impact factor: 1.494

5.  The Changing Landscape of Vestibular Schwannoma Management in the United States--A Shift Toward Conservatism.

Authors:  Matthew L Carlson; Elizabeth B Habermann; Amy E Wagie; Colin L Driscoll; Jamie J Van Gompel; Jeffrey T Jacob; Michael J Link
Journal:  Otolaryngol Head Neck Surg       Date:  2015-06-30       Impact factor: 3.497

Review 6.  Current strategies in management of intracanalicular vestibular schwannoma.

Authors:  Alicia M Quesnel; Michael J McKenna
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2011-10       Impact factor: 2.064

7.  Vestibular schwannoma surgical volume and short-term outcomes in Maryland.

Authors:  Bryan K Ward; Christine G Gourin; Howard W Francis
Journal:  Arch Otolaryngol Head Neck Surg       Date:  2012-06

8.  Vestibular Schwannoma Excision in Sporadic versus Neurofibromatosis Type 2 Populations.

Authors:  Hossein Mahboubi; Marlon M Maducdoc; Amy Y Yau; Kasra Ziai; Yaser Ghavami; Karam W Badran; Majid Al-Thobaiti; Bryan Brandon; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2015-03-19       Impact factor: 3.497

9.  Trends in demographics, charges, and outcomes of patients undergoing excision of sporadic vestibular schwannoma.

Authors:  Omar H Ahmed; Hossein Mahboubi; Sari Lahham; Cory Pham; Hamid R Djalilian
Journal:  Otolaryngol Head Neck Surg       Date:  2013-10-03       Impact factor: 3.497

10.  Predictors of readmission after outpatient otolaryngologic surgery.

Authors:  Umang Jain; Rakesh K Chandra; Stephanie S Smith; Matthew Pilecki; John Y S Kim
Journal:  Laryngoscope       Date:  2014-06-03       Impact factor: 3.325

View more
  4 in total

1.  Medical Malpractice of Vestibular Schwannoma: A 40-Year Review of the United States Legal Databases.

Authors:  Jack Birkenbeuel; Kimberly Vu; Brandon M Lehrich; Mehdi Abouzari; Dillon Cheung; Pooya Khosravi; Ronald Sahyouni; Kasra Ziai; Omid Moshtaghi; Sammy Sahyouni; Hamid R Djalilian
Journal:  Otol Neurotol       Date:  2019-03       Impact factor: 2.311

2.  Variation in Coding Practices for Vestibular Schwannoma Surgery.

Authors:  Wenya Linda Bi; Michael A Mooney; Seungwon Yoon; Saksham Gupta; Michael T Lawton; Kaith K Almefty; C Eduardo Corrales; Ian F Dunn
Journal:  J Neurol Surg B Skull Base       Date:  2018-07-16

3.  Short-Term Morbidity and Predictors of Adverse Events Following Esthesioneuroblastoma Surgery.

Authors:  Khodayar Goshtasbi; Jack L Birkenbeuel; Mehdi Abouzari; Brandon M Lehrich; Tyler M Yasaka; Arash Abiri; Ethan G Muhonen; Frank P K Hsu; Edward C Kuan
Journal:  Am J Rhinol Allergy       Date:  2020-10-29       Impact factor: 2.467

4.  Prognostic value of transcranial facial nerve motor-evoked potentials in predicting facial nerve function following cerebellopontine angle tumorectomy.

Authors:  Hongmei Song; Chengyuan Ma; Dahai Xu; Mingxin Yu; Jiachun Feng; Lichao Sun
Journal:  Medicine (Baltimore)       Date:  2018-10       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.